Aglaia Oncology Funds

Aglaia Oncology Fund is a private equity and venture capital firm specializing in investments in incubation, startup, early stage, PIPEs, bridge financing, companies. It focuses on investments in tools and technologies as well as components of contemporary drug development in biomedical companies in the field of oncology and in biotechnology companies. It invests in companies offering therapies for the prevention and cure of cancer. It usually invests in companies based in Europe. The firm typically invests up to EUR8 million (USD10.28 million) in the companies. It prefers to take an active role in the strategic and operational processes of its portfolio companies. Aglaia Oncology Fund was founded in 2003 and is based in Bilthoven, the Netherlands.